TuHURA Biosciences Inc.

NASDAQ: HURA · Real-Time Price · USD
2.97
-0.03 (-1.00%)
At close: Aug 20, 2025, 9:49 AM

TuHURA Biosciences Balance Sheet Statement

Financials in USD. Fiscal year is undefined.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
Cash & Equivalents
12.66M 3.67M 14.25M 5.55M
Short-Term Investments
n/a n/a n/a n/a
Long-Term Investments
n/a n/a n/a n/a
Other Long-Term Assets
33.77K n/a 33.77K 103.9K
Receivables
222.7K 201.42K 101.42K n/a
Inventory
214.7K n/a n/a n/a
Other Current Assets
316.35K 292.35K 491.77K 135.13K
Total Current Assets
19.61M 4.16M 14.74M 5.68M
Property-Plant & Equipment
322.53K 202.99K 418.55K 617.14K
Goodwill & Intangibles
n/a n/a n/a n/a
Total Long-Term Assets
356.3K 202.99K 452.32K 721.04K
Total Assets
19.97M 4.36M 15.2M 6.4M
Account Payables
3.15M 1.87M 1.92M 413.79K
Deferred Revenue
n/a n/a n/a n/a
Short-Term Debt
n/a n/a n/a 644.07K
Other Current Liabilities
1.16M 137K 675K 456K
Total Current Liabilities
5.33M 3.6M 2.87M 7.15M
Long-Term Debt
n/a 2.32M n/a n/a
Other Long-Term Liabilities
n/a n/a n/a n/a
Total Long-Term Liabilities
42.7K 2.32M 20.74K n/a
Total Liabilities
5.37M 5.92M 2.89M 7.15M
Total Debt
202.54K 2.34M 138.22K 644.07K
Common Stock
42.32K 6.8K 4.53K 4.53K
Retained Earnings
-111.12M -88.47M -59.16M -49.48M
Comprehensive Income
n/a n/a n/a n/a
Shareholders Equity
14.59M -1.56M 12.3M -747.82K
Total Investments
n/a n/a n/a n/a